Full Text View
Tabular View
No Study Results Posted
Related Studies
Tolerability and Efficacy of Rosuvastatin - Fenofibrate Combine Therapy in Korean Patients With Combined Hyperlipidemia
This study has been completed.
Study NCT01414803   Information provided by Yonsei University

First Received on August 3, 2011.   Last Updated on August 10, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hyperlipidemia
Additional conditions recognized in this trial
Hyperlipidemias
More general conditions related to this trial
Dyslipidemias
Lipid Metabolism Disorders
Metabolic Diseases
Interventions listed in this trial
Lipid modification
Additional drug interventions recognized in this trial
Fenofibrate
Rosuvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Hypolipidemic Agents
Lipid Regulating Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Yonsei University


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services